Search Results - "Sussman, Robyn"
-
1
Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma
Published in Cancer cell (11-09-2017)“…We developed an RNA-sequencing-based pipeline to discover differentially expressed cell-surface molecules in neuroblastoma that meet criteria for optimal…”
Get full text
Journal Article -
2
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
Published in Cancer discovery (01-12-2015)“…The CD19 antigen, expressed on most B-cell acute lymphoblastic leukemias (B-ALL), can be targeted with chimeric antigen receptor-armed T cells (CART-19), but…”
Get more information
Journal Article -
3
Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism
Published in Nature (London) (17-12-2015)“…A causal variant is identified at the LMO1 oncogene locus that drives the genetic association of LMO1 with neuroblastoma susceptibility; the causal SNP…”
Get full text
Journal Article -
4
Delayed Accumulation of H3K27me3 on Nascent DNA Is Essential for Recruitment of Transcription Factors at Early Stages of Stem Cell Differentiation
Published in Molecular cell (20-04-2017)“…Recruitment of transcription factors (TFs) to repressed genes in euchromatin is essential to activate new transcriptional programs during cell differentiation…”
Get full text
Journal Article -
5
Primary Pulmonary Myxoid Sarcoma and Myxoid Angiomatoid Fibrous Histiocytoma: A Unifying Continuum With Shared and Distinct Features
Published in The American journal of surgical pathology (01-11-2020)“…Primary pulmonary myxoid sarcoma (PPMS) is a recently reported, exceedingly rare low-grade lung neoplasm characterized by reticular/lace-like growth of spindle…”
Get full text
Journal Article -
6
The Epigenetic Modifier Ubiquitin-specific Protease 22 (USP22) Regulates Embryonic Stem Cell Differentiation via Transcriptional Repression of Sex-determining Region Y-box 2 (SOX2)
Published in The Journal of biological chemistry (16-08-2013)“…Pluripotent embryonic stem cells (ESCs) undergo self-renewal until stimulated to differentiate along specific lineage pathways. Many of the transcriptional…”
Get full text
Journal Article -
7
USP22 Regulates Oncogenic Signaling Pathways to Drive Lethal Cancer Progression
Published in Cancer research (Chicago, Ill.) (01-01-2014)“…Increasing evidence links deregulation of the ubiquitin-specific proteases 22 (USP22) deubitiquitylase to cancer development and progression in a select group…”
Get full text
Journal Article -
8
NTRK point mutations and their functional consequences
Published in Cancer genetics (01-04-2022)“…•NTRK point mutations can be oncogenic driver or acquired resistance mutations.•Some point mutations in NTRK genes respond to targeted…”
Get full text
Journal Article -
9
Validation of a Next-Generation Sequencing Assay Targeting RNA for the Multiplexed Detection of Fusion Transcripts and Oncogenic Isoforms
Published in Archives of pathology & laboratory medicine (1976) (01-01-2020)“…Next-generation sequencing is a high-throughput method for detecting genetic abnormalities and providing prognostic and therapeutic information for patients…”
Get full text
Journal Article -
10
Targeted massively parallel sequencing of mature lymphoid neoplasms: assessment of empirical application and diagnostic utility in routine clinical practice
Published in Modern pathology (01-05-2021)“…Massively parallel sequencing (MPS) has become a viable diagnostic tool to interrogate genetic profiles of numerous tumors but has yet to be routinely adopted…”
Get full text
Journal Article -
11
ROS1 alterations as a potential driver of gliomas in infant, pediatric, and adult patients
Published in Modern pathology (01-11-2023)“…Gliomas harboring oncogenic ROS1 alterations are uncommon and primarily described in infants. Our goal was to characterize the clinicopathological features and…”
Get full text
Journal Article -
12
Rapid and Automated Semiconductor-Based Next-Generation Sequencing for Simultaneous Detection of Somatic DNA and RNA Aberrations in Myeloid Neoplasms
Published in The Journal of molecular diagnostics : JMD (01-02-2023)“…Evaluation of suspected myeloid neoplasms involves testing for recurrent, diagnostically and therapeutically relevant genetic alterations. Current molecular…”
Get full text
Journal Article -
13
Correction: Targeted massively parallel sequencing of mature lymphoid neoplasms: assessment of empirical application and diagnostic utility in routine clinical practice
Published in Modern pathology (01-02-2022)“…A Correction to this paper has been published: https://doi.org/10.1038/s41379-020-00733-2…”
Get full text
Journal Article -
14
Epigenomic profiling of neuroblastoma cell lines
Published in Scientific data (14-04-2020)“…Understanding the aberrant transcriptional landscape of neuroblastoma is necessary to provide insight to the underlying influences of the initiation,…”
Get full text
Journal Article -
15
CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma
Published in Frontiers in oncology (06-03-2020)“…We developed a computational pipeline designed to use RNA sequencing ( = 136) and gene expression profiling ( = 250) data from neuroblastoma tumors to identify…”
Get full text
Journal Article -
16
Differential killing of CD56-expressing cells by drug-conjugated human antibodies targeting membrane-distal and membrane-proximal non-overlapping epitopes
Published in mAbs (18-05-2016)“…CD56 (NCAM, neural cell adhesion molecule) is over-expressed in many tumor types, including neuroblastoma, multiple myeloma, small cell lung cancer, ovarian…”
Get full text
Journal Article -
17
Interpretative differences of combined cytogenetic and molecular profiling highlights differences between MRC and ELN classifications of AML
Published in Cancer genetics (01-08-2021)“…•Correlation of cytogenetic prognostic risk stratification with mutations in newly diagnosed de novo Acute Myeloid Leukemia.•Correlation of cytogenetic…”
Get full text
Journal Article -
18
Chemotherapy-resistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the Non-SP, a higher expression of c-Myc and TRAIL-receptor DR4
Published in Cancer biology & therapy (01-09-2007)“…Cancer stem cells are resistant to chemotherapy and provide an important target for drug development. We found that, surprisingly, the dye-effluxing side…”
Get full text
Journal Article -
19
Validation of a next-generation sequencing oncology panel optimized for low input DNA
Published in Cancer genetics (01-12-2018)“…•Hotspot panel for poor quality and low input oncology specimens.•Assay input DNA as low as 0.5-1 ng. One caveat of next-generation sequencing (NGS)-based…”
Get full text
Journal Article -
20
Inhibition of the Single Downstream Target BAG1 Activates the Latent Apoptotic Potential of MYC
Published in Molecular and Cellular Biology (01-12-2011)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article